AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2013

Feb 8, 2013

30870_dirs_2013-02-08_206f4079-9ce3-4652-b6b2-9472ce55fdda.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2013-02-07

Reporting Person: PARSHALL B LYNNE (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-02-07	Non-Qualified Stock Option (right to buy)	$1.1	A	50000	Acquired	2023-02-07	Common Stock (50000)	Direct

Footnotes

F1: This option shall vest and become exercisable as to 50,000 shares divided into equal monthly installments such that the option shall be 100% vested on February 7, 2016.